|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent CAPR insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why CAPR insider buys are important for investors to follow.
Date | Insider | Price | Amount |
10-12-2023 Insider Buy |
David B. Musket
|
$2.75
CAGR »
|
$1,127.50 410 shares |
10-10-2023 Insider Buy |
Earl M. Collier Jr.
|
$2.83
CAGR »
|
$28,300.00 10,000 shares |
10-9-2023 Insider Buy |
David B. Musket
|
$2.82
CAGR »
|
$14,334.06 5,083 shares |
10-6-2023 Insider Buy |
Paul Gisbert Auwaerter
|
$2.84
CAGR »
|
$14,200.00 5,000 shares |
10-4-2023 Insider Buy |
David B. Musket
|
$2.90
CAGR »
|
$7,250.00 2,500 shares |
7-6-2022 Insider Buy |
Xavier Avat CHIEF BUSINESS OFFICER |
$3.73
CAGR »
|
$9,322.85 2,500 shares |
5-9-2017 Insider Buy |
Sinai Medical Center Cedars >10% Owner |
$3.10
CAGR »
|
$3,549,999.10 1,145,161 shares |
5-9-2017 Insider Buy |
Louis Manzo Director |
$3.10
CAGR »
|
$31,000.00 10,000 shares |
5-9-2017 Insider Buy |
David B. Musket Director |
$3.10
CAGR »
|
$77,500.00 25,000 shares |
9-21-2016 Insider Buy |
Sinai Medical Center Cedars >10% Owner |
$3.20
CAGR »
|
$1,000,000.00 312,500 shares |
3-16-2016 Insider Buy |
Louis J. Grasmick Director |
$2.40
CAGR »
|
$219,285.60 91,369 shares |
3-16-2016 Insider Buy |
Louis Manzo Director |
$2.40
CAGR »
|
$240,000.00 100,000 shares |
3-16-2016 Insider Buy |
Anthony Bergmann Vice President of Finance |
$2.40
CAGR »
|
$4,872.00 2,030 shares |
3-16-2016 Insider Buy |
Linda Marban Chief Executive Officer |
$2.40
CAGR »
|
$24,364.80 10,152 shares |
3-16-2016 Insider Buy |
Karen Krasney EVP, General Counsel |
$2.40
CAGR »
|
$9,744.00 4,060 shares |
3-16-2016 Insider Buy |
Leland Gershell CHIEF FINANCIAL OFFICER |
$2.40
CAGR »
|
$5,040.00 2,100 shares |
3-16-2016 Insider Buy |
Sinai Medical Center Cedars >10% Owner |
$2.40
CAGR »
|
$999,998.40 416,666 shares |
3-16-2016 Insider Buy |
Edward A. St. John >10% Owner |
$2.40
CAGR »
|
$1,999,996.80 833,332 shares |
8-20-2015 Insider Buy |
Louis J. Grasmick Director |
$4.11
CAGR »
|
$48,893.82 11,900 shares |
8-19-2015 Insider Buy |
Eduardo Marban >10% Owner |
$4.36
CAGR »
|
$80,228.00 18,400 shares |
8-19-2015 Insider Buy |
Linda Marban Chief Executive Officer |
$4.36
CAGR »
|
$80,228.00 18,400 shares |
1-21-2015 Insider Buy |
Edward A. St. John >10% Owner |
$3.52
CAGR »
|
$2,999,996.56 851,546 shares |
1-21-2015 Insider Buy |
Sinai Medical Center Cedars >10% Owner |
$3.52
CAGR »
|
$2,999,996.56 851,546 shares |
1-21-2015 Insider Buy |
Joshua A. Kazam Director |
$3.52
CAGR »
|
$24,999.21 7,096 shares |
1-21-2015 Insider Buy |
Louis J. Grasmick Director |
$3.52
CAGR »
|
$499,998.25 141,924 shares |
1-21-2015 Insider Buy |
David B. Musket Director |
$3.52
CAGR »
|
$249,999.13 70,962 shares |
1-21-2015 Insider Buy |
Karen Krasney EVP, General Counsel |
$3.52
CAGR »
|
$24,999.21 7,096 shares |
1-21-2015 Insider Buy |
Louis Manzo Director |
$3.52
CAGR »
|
$99,996.83 28,384 shares |
Also See: Institutional Holders of CAPR
Also See: SEC filings
Below we present the annualized performance delivered by CAPR stock since 10-12-2023 (the date of the most recent
insider purchase). The performance of the investment from the time CAPR insider buying occurred is the ultimate
test of whether insiders were right about CAPR being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/13/2023 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$2.86 |
|
End price/share: |
$4.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
68.53% |
|
Annualized Gain: |
129.61% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$16,853.00 |
|
Years: |
0.53 |
|
CAPR Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent CAPR insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CAPR
|
|